Abstract
Aim: To investigate whether genes implicated in dementia pathogenesis are differently methylated in peripheral blood. Materials & methods: Participants included 160 cognitively healthy individuals aged 70+ years: 73 who were subsequently diagnosed with dementia and 87 controls matched on age, gender, education, smoking and baseline cognition. A total of 49 participants also provided blood samples at diagnosis. Blood DNA methylation of APOE, APP, BDNF, PIN1, SNCA and TOMM40 was examined. Results: A total of 56 of 299 probes were differentially methylated in dementia compared with controls and 39 probes prior to diagnosis. The greatest effect size was in APP (cg19423170, Δ-8.32%, adjusted p = 0.009 at diagnosis; cg19933173, Δ-4.18%, adjusted p < 0.0001 prediagnosis). Conclusion: Genes implicated in dementia pathogenesis show differential blood methylation in dementia, even prior to diagnosis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2109-2123 |
| Number of pages | 15 |
| Journal | Epigenomics |
| Volume | 12 |
| Issue number | 23 |
| DOIs | |
| Publication status | Published - Dec 2020 |
| Externally published | Yes |
Keywords
- APOE
- APP
- BDNF
- DNA methylation
- PIN1
- SNCA
- TOMM40
- biomarker
- blood
- dementia